[go: up one dir, main page]

MXPA99002575A - Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga. - Google Patents

Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga.

Info

Publication number
MXPA99002575A
MXPA99002575A MXPA99002575A MX9902575A MXPA99002575A MX PA99002575 A MXPA99002575 A MX PA99002575A MX PA99002575 A MXPA99002575 A MX PA99002575A MX 9902575 A MX9902575 A MX 9902575A MX PA99002575 A MXPA99002575 A MX PA99002575A
Authority
MX
Mexico
Prior art keywords
alkanes
amides
fatty acids
alcohol
long
Prior art date
Application number
MXPA99002575A
Other languages
English (en)
Inventor
David H Katz
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/916,624 external-priority patent/US5952392A/en
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of MXPA99002575A publication Critical patent/MXPA99002575A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describen composiciones terapeuticas que incluyen un tensioactivo no ionico combinado con acidos grasos, alcanos, amidas o alcoholes mono-insaturados de cadena larga, particularmente alcohol estearilico, alcohol erucilico, alcohol brassilico, alcohol araquidilico, n-docosano, acido n-docosanoico, erucamida y acido estearico o mezclas de los mismos, ingredientes activos. Se describen los metodos para evitar o tratar las infecciones virales, el tratamiento de la inflamacion de la piel o las membranas ola inhibicion de la proliferacion celular utilizando tales composiciones.
MXPA99002575A 1996-09-17 1997-09-10 Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga. MXPA99002575A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71500996A 1996-09-17 1996-09-17
US08/916,624 US5952392A (en) 1996-09-17 1997-08-22 Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
PCT/US1997/016007 WO1998011887A2 (en) 1996-09-17 1997-09-10 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides

Publications (1)

Publication Number Publication Date
MXPA99002575A true MXPA99002575A (es) 2004-07-29

Family

ID=27109257

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA99002575A MXPA99002575A (es) 1996-09-17 1997-09-10 Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga.

Country Status (16)

Country Link
EP (2) EP1557167A1 (es)
JP (1) JP3739098B2 (es)
KR (2) KR100528815B1 (es)
CN (1) CN1213748C (es)
AT (1) ATE299700T1 (es)
AU (1) AU742929B2 (es)
BR (1) BR9711501A (es)
CA (1) CA2273960C (es)
DE (1) DE69733778T2 (es)
DK (1) DK1001759T3 (es)
ES (1) ES2245004T3 (es)
IL (2) IL163865A0 (es)
MX (1) MXPA99002575A (es)
PL (1) PL189618B1 (es)
PT (1) PT1001759E (es)
WO (1) WO1998011887A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
ATE442844T1 (de) 1996-11-14 2009-10-15 Lipomedica Ehf Topische zusammensetzungen enthaltend als therapeutisch aktiven wirkstoff ein monoglycerid zur behandlung von schleimhautinfektionen
WO1998058627A1 (en) * 1997-06-20 1998-12-30 Sabine Ebeling A skin-protective composition
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
SE0102289D0 (sv) * 2001-06-27 2001-06-27 Anders Hamberger New use of compound
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ ｎ−ドコサノールによるウイルス阻害
RU2337093C2 (ru) 2002-10-10 2008-10-27 Йеда Рисерч Энд Дивелопмент Ко.Лтд. Основные эфиры жирных кислот и их применение в качестве противовоспалительных или иммуномодулирующих средств
KR200449517Y1 (ko) * 2008-01-23 2010-07-15 김영중 선박의 조향장치용 헬름
KR100971276B1 (ko) * 2008-05-29 2010-07-20 김영중 조향장치
WO2011112997A1 (en) 2010-03-11 2011-09-15 Chemic Laboratories, Inc. Novel compositions and methods
CN102702061B (zh) * 2012-06-07 2013-04-24 浙江维康药业有限公司 一种盐酸水苏碱化合物及含有该化合物的药物组合物
JP6125962B2 (ja) * 2013-09-24 2017-05-10 株式会社デンソー 抗ウイルス剤
FR3080034B1 (fr) * 2018-04-16 2020-04-24 L'oreal Composition cosmetique pour fibres keratiniques
FR3080038B1 (fr) * 2018-04-16 2020-10-09 Oreal Composition cosmetique pour fibres keratiniques
KR102611242B1 (ko) * 2021-05-17 2023-12-08 충남대학교 산학협력단 알케인을 유효성분으로 함유하는 항바이러스용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
US5194451A (en) * 1989-11-02 1993-03-16 Katz David H Systemic anti-inflammatory treatment
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
WO1994016061A1 (en) * 1993-01-15 1994-07-21 Micro Vesicular Systems, Inc. Method of inhibiting viral reproduction
ES2299173T3 (es) * 1993-12-13 2008-05-16 Avanir Pharmaceuticals Formulaciones de n-docosanol y ester de sacarosa.

Also Published As

Publication number Publication date
JP2001521490A (ja) 2001-11-06
KR100528816B1 (ko) 2005-11-16
ATE299700T1 (de) 2005-08-15
AU4339797A (en) 1998-04-14
CA2273960C (en) 2003-12-30
AU742929B2 (en) 2002-01-17
EP1557167A1 (en) 2005-07-27
WO1998011887A2 (en) 1998-03-26
EP1001759A2 (en) 2000-05-24
ES2245004T3 (es) 2005-12-16
PT1001759E (pt) 2005-10-31
IL163865A0 (en) 2005-12-18
CN1244121A (zh) 2000-02-09
IL129033A0 (en) 2000-02-17
DE69733778D1 (de) 2005-08-25
CN1213748C (zh) 2005-08-10
KR20000036210A (ko) 2000-06-26
KR100528815B1 (ko) 2005-11-16
BR9711501A (pt) 2004-05-25
DK1001759T3 (da) 2005-10-10
DE69733778T2 (de) 2006-04-20
CA2273960A1 (en) 1998-03-26
PL189618B1 (pl) 2005-08-31
WO1998011887A3 (en) 1998-06-25
PL332455A1 (en) 1999-09-13
KR20030097605A (ko) 2003-12-31
EP1001759B1 (en) 2005-07-20
JP3739098B2 (ja) 2006-01-25

Similar Documents

Publication Publication Date Title
MXPA99002575A (es) Composicion para la inhibicion viral, que comprende amidas, acidos grasos, alcanos y alcoholes de cadena larga.
ES2170256T3 (es) Composiciones para el suministro topico de ingredientes activos.
ES2154650T3 (es) Composicion que comprende una formulacion con factor de coagulacion viii, procedimiento para su preparacion y uso de un tensioactivo como estabilizador.
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
EP0730465A4 (en) USE OF ANGIOTENSIN III AND ITS ANALOGS FOR TISSUE REPAIR
NO20000085L (no) Forbedrede fremgangsmåter og preparater for behandling av ereksjonsdysfunksjon hos menn
MX9708150A (es) Composiciones antibacteriales para curar heridas y metodos para preparar y utilizar las mismas.
NZ295303A (en) Sunscreen composition comprising a sunscreen agent, an anti-inflammatory agent and a composition for healing wounds
IL114641A0 (en) Pharmaceutical compositions containing fluoxetine
BR9507730A (pt) Uso de formulações em gel como composições de tratamento
MX9606502A (es) Composiciones antiqueratoliticas y curativas para heridas y metodos para preparar y utilizar las mismas.
ES2068797T3 (es) Producto para el tratamiento del cabello y procedimiento para su aplicacion.
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
ES2161759T3 (es) Derivados de profarmacos de inhibidores de enzimas con grupos hidroxilo, procedimiento para su preparacion y su utilizacion.
DK0713386T3 (da) Sprayformulering med kølende effekt
CA2445953A1 (en) VIRAL INHIBITION USING ALCOHOLS, ALKANES, FATTY ACIDS AND LONG CHAIN AMIDES
AU5957198A (en) A process for inhibiting stem elongation in bulbous plants
ES2113803A1 (es) Metodo para el tratamiento de plantas.
AR022017A1 (es) Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica
DE69914327D1 (de) Biologisch aktive mikrodispersionszusammensetzung
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
DK0925064T3 (da) 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst
JPS53113025A (en) Proliferation inhibitor for microorganisms
IL139898A0 (en) Anti-germ-attachment composition